Zoe Johnson

Zoe Johnson

Company: iOnctura

Job title: Chief Scientific Officer


Zoë holds a PhD in Pharmacology from King’s College London and has more than 15 years of experience in the biopharmaceutical industry across a range of therapy areas including oncology, autoimmune & inflammatory diseases and allergy. Her main area of expertise is in building preclinical pharmacology packages and supporting the transition of small and large molecules into early clinical development. Zoë is the CSO at iOnctura, a biopharmaceutical company developing a pipeline of next generation molecules for the treatment of cancer and fibrosis. Zoë has previously worked at UCB, Merck KGaA and Novimmune and is based in Geneva, Switzerland.

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.